Back to Explorer

Procedures for Class II Device Exemptions from Premarket Notification, Guidance for Industry and CDRH Staff

FinalCenter for Devices and Radiological Health02/18/1998

Description

This document is intended to provide guidance. It represents the Agency's current thinking on the above. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute, regulations, or both.

Scope & Applicability

Product Classes

2
In Vitro Diagnostic Device

IVDs for emerging pathogens during a Section 564 declared emergency

Class II Device

Devices subject to section 522 postmarket surveillance orders; devices subject to postmarket surveillance orders

Stakeholders

2
Advisory Panel

FDA may seek advice when considering the initiation or progress of a PAS

Petitioner

Party submitting a citizen petition; party evaluating whether a food allergen is of public health importance; Party recommended to conduct systematic reviews and evidence scoring.

Regulatory Context

Attributes

2
prescription battery powered

limits the exemption to prescription battery powered devices

Safety and Effectiveness

Cybersecurity is part of device safety and effectiveness

Related CFR Sections (2)

See Also (8)

Procedures for Class II Device Exemptions from Premarket Notification, Guidance for Industry and CDRH Staff | Guideline Explorer | BioRegHub